Faculty Opinions recommendation of CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. — Alberto Mantovani | RDL Network
A.B and I.L.W. conceived of and designed all experiments. A.A.B., R.E.B., and M.M. performed all flow cytometry analyses, generated human macrophages, and performed in vitro phagocytosis assays. A.A.B, R.E.B., and M.M. performed in vivo experiments and S.A.B. assisted with in vivo phagocytosis measurements. B.Z. assisted with the design of neuraminidase experiments. M.K. performed single cell RNA-sequencing analysis. J.H. assisted with live-cell microscopy. L.J.B
Qi Guo, Melissa Millard, Christine Wilhelm, Ashley Elrod, Nick Erdman, Lacey E. Dobrolecki, Brian McKinley, Mary Rippon, Wendy R. Cornett, John M. Rinkliff, Amanda Scopteuolo, Linda G. Gray, James Epling, Barbara Garner, Jeff Hanna, Eric S. Mcgill, C. David Williams, David P. Schammel, David Kaplan, Christopher L. Corless, Jeff Edenfield, Michael T. Lewis, Howland E. Crosswell, Teresa M. DesRochers
Manuel Boix-Chornet, Mario F. Fraga, Ana Villar‐Garea, Rosalía Caballero, Jesús Espada, Antonio Núñez, Juan Casado‐Vela, Cristina Largo, J. Ignacio Casal, Juan C. Cigudosa, Luís Franco, Manel Esteller, Esteban Ballestar
Benjamin G. Gowen, Bryan Chim, Caleb Marceau, Trever T. Greene, Patrick Burr, Jeanmarie R. Gonzalez, Charles R. Hesser, Peter A. Dietzen, Teal Russell, Alexandre Iannello, Laurent Coscoy, Charles L. Sentman, Jan E. Carette, Stefan A. Muljo, David H Raulet
Discussion(0)
No comments yet. Be the first to comment.